Opioids News and Research

RSS
An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. The receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.
Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

Cancer pain drug market to be $3.7 billion in 2018

Cancer pain drug market to be $3.7 billion in 2018

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

FDA approves Par Pharmaceutical's new painkiller drug

FDA approves Par Pharmaceutical's new painkiller drug

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Chronic pain patients with depression three times more likely to receive opioid medications

Chronic pain patients with depression three times more likely to receive opioid medications

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain

Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain

Adolor commences clinical testing of its oral mu opioid receptor antagonist

Adolor commences clinical testing of its oral mu opioid receptor antagonist

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

FDA approves Covidien's Abbreviated New Drug Application for CII

FDA approves Covidien's Abbreviated New Drug Application for CII

Data from Phase II clinical trial of NKTR-118 presented

Data from Phase II clinical trial of NKTR-118 presented

Alkermes commences ALKS 37 phase 1 clinical trial for the treatment of opioid-induced constipation

Alkermes commences ALKS 37 phase 1 clinical trial for the treatment of opioid-induced constipation

Positive results from KAI Pharmaceuticals' pain therapeutic program

Positive results from KAI Pharmaceuticals' pain therapeutic program

FDA launches web page with information on how to dispose of certain drugs

FDA launches web page with information on how to dispose of certain drugs

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

QRxPharma signs contractual agreement with Patheon

QRxPharma signs contractual agreement with Patheon